-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Bouvel Investment Partners LLC Has $1.14 Million Holdings in Cerus Co. (NASDAQ:CERS)
Bouvel Investment Partners LLC Has $1.14 Million Holdings in Cerus Co. (NASDAQ:CERS)
Bouvel Investment Partners LLC grew its stake in Cerus Co. (NASDAQ:CERS – Get Rating) by 1.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 214,503 shares of the biotechnology company's stock after buying an additional 3,008 shares during the quarter. Bouvel Investment Partners LLC owned 0.12% of Cerus worth $1,135,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in CERS. Bank of America Corp DE boosted its holdings in shares of Cerus by 22.4% in the fourth quarter. Bank of America Corp DE now owns 326,525 shares of the biotechnology company's stock valued at $2,223,000 after buying an additional 59,839 shares during the period. BNP Paribas Arbitrage SA boosted its holdings in shares of Cerus by 50.0% in the fourth quarter. BNP Paribas Arbitrage SA now owns 44,982 shares of the biotechnology company's stock valued at $306,000 after buying an additional 15,003 shares during the period. Teacher Retirement System of Texas boosted its holdings in Cerus by 22.7% during the fourth quarter. Teacher Retirement System of Texas now owns 33,292 shares of the biotechnology company's stock worth $227,000 after purchasing an additional 6,168 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in Cerus by 485.7% during the fourth quarter. Renaissance Technologies LLC now owns 642,473 shares of the biotechnology company's stock worth $4,375,000 after purchasing an additional 532,773 shares during the last quarter. Finally, Williams Jones Wealth Management LLC. acquired a new position in Cerus during the fourth quarter worth $136,000. Institutional investors and hedge funds own 84.72% of the company's stock.
Get Cerus alerts:Cerus Stock Down 0.5 %
CERS traded down $0.02 during trading hours on Wednesday, hitting $3.73. 16,639 shares of the company's stock were exchanged, compared to its average volume of 1,551,412. Cerus Co. has a 1-year low of $3.69 and a 1-year high of $8.06. The stock's 50-day moving average is $4.84 and its two-hundred day moving average is $5.04. The stock has a market cap of $660.55 million, a price-to-earnings ratio of -15.62 and a beta of 1.14. The company has a quick ratio of 1.73, a current ratio of 2.08 and a debt-to-equity ratio of 0.53.
Insider Buying and Selling
In related news, insider Richard J. Benjamin sold 10,000 shares of the stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $5.12, for a total transaction of $51,200.00. Following the completion of the transaction, the insider now owns 172,665 shares in the company, valued at $884,044.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 7.33% of the stock is currently owned by corporate insiders.Cerus Company Profile
(Get Rating)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Recommended Stories
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
- General Mills: Superior Returns With Less Volatility
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- Is Ford Rolling To A Rebound After Its Q3 Warning
Want to see what other hedge funds are holding CERS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerus Co. (NASDAQ:CERS – Get Rating).
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
Bouvel Investment Partners LLC grew its stake in Cerus Co. (NASDAQ:CERS – Get Rating) by 1.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 214,503 shares of the biotechnology company's stock after buying an additional 3,008 shares during the quarter. Bouvel Investment Partners LLC owned 0.12% of Cerus worth $1,135,000 at the end of the most recent reporting period.
根据Bouvel Investment Partners LLC向美国证券交易委员会(Securities&Exchange Commission)的最新披露,该公司在第二季度增持了Cerus Co.(纳斯达克代码:CERS-GET Rating)的股份1.4%。该公司在本季度额外购买了3,008股后,持有这家生物技术公司的214,503股股票。在最近的报告期结束时,Bouvel Investment Partners LLC拥有Cerus 0.12%的股份,价值1,135,000美元。
Several other institutional investors and hedge funds also recently made changes to their positions in CERS. Bank of America Corp DE boosted its holdings in shares of Cerus by 22.4% in the fourth quarter. Bank of America Corp DE now owns 326,525 shares of the biotechnology company's stock valued at $2,223,000 after buying an additional 59,839 shares during the period. BNP Paribas Arbitrage SA boosted its holdings in shares of Cerus by 50.0% in the fourth quarter. BNP Paribas Arbitrage SA now owns 44,982 shares of the biotechnology company's stock valued at $306,000 after buying an additional 15,003 shares during the period. Teacher Retirement System of Texas boosted its holdings in Cerus by 22.7% during the fourth quarter. Teacher Retirement System of Texas now owns 33,292 shares of the biotechnology company's stock worth $227,000 after purchasing an additional 6,168 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in Cerus by 485.7% during the fourth quarter. Renaissance Technologies LLC now owns 642,473 shares of the biotechnology company's stock worth $4,375,000 after purchasing an additional 532,773 shares during the last quarter. Finally, Williams Jones Wealth Management LLC. acquired a new position in Cerus during the fourth quarter worth $136,000. Institutional investors and hedge funds own 84.72% of the company's stock.
其他几家机构投资者和对冲基金最近也改变了他们在CER的头寸。去年第四季度,美国银行(Bank Of America Corp DE)增持了Cerus的股票22.4%。美国银行DE现在拥有326,525股生物技术公司的股票,价值2223,000美元,在此期间又购买了59,839股。法国巴黎银行套利公司在第四季度增持了50.0%的Cerus股票。法国巴黎银行套利公司现在持有这家生物技术公司44,982股股票,价值306,000美元,在此期间又购买了15,003股。德克萨斯州教师退休系统在第四季度将其在Cerus的持有量增加了22.7%。德克萨斯州教师退休系统在上个季度购买了6,168股后,现在拥有33,292股这家生物技术公司的股票,价值227,000美元。文艺复兴科技有限责任公司在第四季度增持了Cerus 485.7%的股份。复兴科技有限责任公司现在拥有这家生物技术公司642,473股票,价值4375,000美元,在上个季度又购买了532,773股票。最后,威廉姆斯·琼斯财富管理有限责任公司。在第四季度收购了Cerus的一个新头寸,价值136,000美元。机构投资者和对冲基金持有该公司84.72%的股票。
Cerus Stock Down 0.5 %
Cerus股价下跌0.5%
CERS traded down $0.02 during trading hours on Wednesday, hitting $3.73. 16,639 shares of the company's stock were exchanged, compared to its average volume of 1,551,412. Cerus Co. has a 1-year low of $3.69 and a 1-year high of $8.06. The stock's 50-day moving average is $4.84 and its two-hundred day moving average is $5.04. The stock has a market cap of $660.55 million, a price-to-earnings ratio of -15.62 and a beta of 1.14. The company has a quick ratio of 1.73, a current ratio of 2.08 and a debt-to-equity ratio of 0.53.
CER在周三的交易时段下跌0.02美元,触及3.73美元。该公司股票成交量为16,639股,而其平均成交量为1,551,412股。Cerus Co.的一年低点为3.69美元,一年高位为8.06美元。该股的50日移动均线切入位为4.84美元,200日移动均线切入位为5.04美元。该股市值为6.6055亿美元,市盈率为-15.62倍,贝塔系数为1.14。该公司的速动比率为1.73,流动比率为2.08,债务权益比率为0.53。
Insider Buying and Selling
内幕买卖
Cerus Company Profile
Cerus公司简介
(Get Rating)
(获取评级)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Cerus公司是一家生物医药产品公司。该公司专注于开发拦截血液系统并将其商业化,以增强血液安全。其拦截血液系统,这是一项控制生物复制的专利技术,旨在减少用于输血的捐献血液成分中的血源性病原体。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
- General Mills: Superior Returns With Less Volatility
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- Is Ford Rolling To A Rebound After Its Q3 Warning
- 免费获取StockNews.com关于Cerus的研究报告(CERS)
- 连续60年提高股息的3只防御性股票
- 通用磨坊:波动性更小、回报更高
- 3家航空公司股票陷入持有格局
- Roku股票下跌,但并未出局
- 福特在第三季度发出警告后是否正在反弹
Want to see what other hedge funds are holding CERS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerus Co. (NASDAQ:CERS – Get Rating).
想看看还有哪些对冲基金持有CER吗?访问HoldingsChannel.com获取Cerus Co.(纳斯达克:CERS-GET Rating)的最新13F备案和内幕交易信息。
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Cerus Daily》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cerus和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧